The trend of cutaneous lesions during COVID-19 pandemic
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Besides predominant respiratory and gastrointestinal manifestations, reports on cutaneous manifestations in COVID-19 patients are being noted increasingly. A study was conducted to estimate the prevalence of cutaneous manifestations in COVID-19 patients.

This study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. Studies reporting cutaneous manifestations in COVID-19 patients were included. Irrespective of the heterogeneity of data. Out of 15,143 articles, 2086 articles were selected for the full-text read. Forty-three articles were selected for qualitative analysis, of which 10 articles were included for meta-analysis. The pooled prevalence of overall cutaneous lesions was 5.69. The pooled prevalence of other outcome parameters were as follows: viral exanthem like presentation 4.15, maculopapular rash 3.81, vesiculobullous lesions 1.67.

The estimated prevalence of cutaneous manifestations in COVID-19 was 5.69%. Other manifestations were urticaria, chilblain- like lesions, livedo reticularis, and finger/toe gangrene. Although it is premature to conclude the prevalence of the cutaneous manifestations during this ongoing pandemic, our report may be a stimulating factor for the physicians to perform further vigilant streamlined reporting of cutaneous manifestations in COVID-19 patients to estimate the final prevalence.

Source: https://onlinelibrary.wiley.com/doi/10.1111/ijd.15154
Like
Comment
Share